SGLT2 Inhibitors
Sort by:
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,357 views
- November 30, 2023
- 20
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 3
FEATURING
James Gavin Iii
- 645 views
- November 30, 2023
- 10
Keck School of Medicine of USC
Heterogeneity and Therapy Options for T2D: Q&A Discussion
FEATURING
Anne Peters,
Nairi Berner
- 8 views
- November 30, 2023
Keck School of Medicine of USC
Should Obesity Be the Treatment Target in Type 2 Diabetes?
FEATURING
Jaime Almandoz
- 498 views
- November 30, 2023
- 4
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who
FEATURING
Qin Yang
- 946 views
- November 24, 2023
- 5
AHA 2023 Insights
AHA 2023 Insights: Estimated Lifetime Benefits of SGLT2i, GLP-1 RA and ns-MRA in People with Type 2 Diabetes and Albuminuria
FEATURING
Brendon Neuen
- 178 views
- November 23, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors - Clinical Questions for HFpEF That Are Yet to Be Answered Back to the Lab
FEATURING
Joseph Hill
- 628 views
- November 23, 2023
- 8
Jefferson Health
Flavors of Diabetes - Maturity Onset of the Young (MODY)
FEATURING
Monika Shirodkar
- 218 views
- November 23, 2023
- 1
Jefferson Health
Diabesity: New Trends in Management
FEATURING
Kevin Furlong
- 826 views
- November 23, 2023
- 11
Primary Care Education Consortium
Road Map & Speed Bumps in the Management of T2DM
FEATURING
Louis Kuritzky
- 241 views
- November 21, 2023
- 1
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,706 views
- November 21, 2023
- 19
AHA 2023 Insights
AHA 2023 Insights: SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
FEATURING
Aldostefano Porcari
- 148 views
- November 21, 2023
- 2
Penn Medicine Heart and Vascular Center
Treatments for CV Risk Reduction: Clinical Case Discussion
- 86 views
- November 21, 2023
- 1
Penn Medicine Heart and Vascular Center
ReLOOK at Treatment Options for Mitral Regurgitation and Heart Failure
FEATURING
Hansie Mathelier
- 127 views
- November 8, 2023
- 2
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finally Have Clothes?
FEATURING
Sean Pinney
- 3,011 views
- November 8, 2023
- 26
Top Ten Topics in Clinical Cardiology 2023
Chronic Coronary Disease Guidelines: What's New Besides the Name?
FEATURING
David Maron
- 675 views
- November 8, 2023
- 5
Penn Medicine Heart and Vascular Center
How Do I Safely Introduce and Monitor SGLT-2 Inhibitors?
FEATURING
Anastassia Amaro
- 624 views
- November 8, 2023
- 4
MUSC Cardiology
Mechanisms of Diastolic Dysfunction (Fibrosis, Myofilaments, etc) and How to Make Them Therapeutic Targets
FEATURING
Michael Zile
- 40 views
- September 14, 2023
Scripps Health
A Rheumatology Tour: Myths & Pearls 2023
FEATURING
Richard Keating
- 119 views
- September 12, 2023
ERA 2023 Insights
ERA 2023 Insights: Serendipity of SGLT2 Inhibition in Diabetes and Non Diabetes CKD
FEATURING
Vjollca Godanci Kelmendi
- 223 views
- September 7, 2023
- 3